Adimab (United States)

Overview

• HeadquartersLebanon¹
• Websitewww.adimab.com
• Incorporated inDE⁴
• Business address7 Lucent Drive, Lebanon, Nh 03766⁴

See how the biggest companies compare on our leaderboards

Corporate structure

Adimab (United States) sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Timeline

1. 2007Founded Founded¹

Stakes it holds

Adimab (United States) has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

• Invivyd, Inc.SCHEDULE 13D/A Mar 30, 2022 to Dec 29, 2025⁵

SEC filer profile

How Adimab (United States) is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARAdimab, LLC²
• CIK0001545672
• Employer ID (EIN)80-0669559²
• Incorporated inDelaware²
• Fiscal year endsDecember 31²
• Business address7 Lucent Drive, Lebanon, NH 03766²
• Phone603-643-7110²
• On EDGAR sinceApr 2, 2012²
• Filings14 in all: 144 (3), 4 (3), SC 13D/A (3), SCHEDULE 13D/A (2), 3 (1), D (1), SC 13D (1)²

Links

• Websitewww.adimab.com¹
• WikidataQ100955919
• SEC EDGARCIK 1545672